Table 1.
Baseline characteristics of two groups.
| ESAA group n = 29 | Medication treatment group n = 14 | p value | |
|---|---|---|---|
| Gender (male/female) | 12/17 | 8/6 | 0.3315 |
| Age (average ± standard deviation) | 71.9 ± 3.7 | 70.7 ± 3.9 | 0.3313 |
| Degree of vertebrobasilar artery stenosis | 81.7 ± 8.5 | 78.8 ± 6.6 | 0.2687 |
| Hypertension (cases %) | 24 (82.8) | 12 (85.7) | 0.8057 |
| Abnormal lipid metabolism (cases %) | 10 (34.5) | 5 (35.7) | 0.9367 |
| Smoking (cases %) | 9 (31.0) | 4 (28.6) | 0.8691 |
| Diabetes mellitus (cases %) | 12 (41.4) | 6 (42.9) | 0.9267 |
| BMI (kg/m2 (average ± standard deviation)) | 26.2 ± 2.5 | 25.8 ± 3.1 | 0.6519 |
ESAA: endovascular stent-assistant angioplasty; BMI: body mass index.